1. Analysis of Select Herpes Simplex Virus 1 (HSV-1) Proteins for Restriction of Human Immunodeficiency Virus Type 1 (HIV-1): HSV-1 gM Protein Potently Restricts HIV-1 by Preventing Intracellular Transport and Processing of Env gp160.Arachchige, S.P., W. Henke, A. Pramanik, M. Kalamvoki, and E.B. Stephens. Journal of Virology, 2018. 92(2): p. e01476-01417. PMID[29093081]. PMCID[PMC5752927].
[PubMed]. HIV_01_2018.
2. Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease Inhibitors. Bungard, C.J., P.D. Williams, J. Schulz, C.M. Wiscount, M.K. Holloway, H.M. Loughran, J.J. Manikowski, H.P. Su, D.J. Bennett, L.H. Chang, X.J. Chu, A. Crespo, M.P. Dwyer, K. Keertikar, G.J. Morriello, A.W. Stamford, S.T. Waddell, B. Zhong, B. Hu, T. Jo, T.L. Diamond, C. Bahnck-Teets, S.S. Carroll, J.F. Fay, X. Min, W. Morris, J.E. Ballard, M.D. Miller, and J.A. McCauley. ACSMedicinal Chemistry Letters, 2017. 8(12): p. 1292-1297. PMID[29259750]. PMCID[PMC5733263].
[PubMed]. HIV_01_2018.
3. Neo-clerodane Diterpenoids from the Whole Plants of Scutellaria formosana. Chen, X., W. Chen, G. Chen, C. Han, J.J. He, X. Zhou, Z. Yu, C. Dai, and X. Song. Phytochemistry, 2018. 145: p. 1-9. PMID[29031114].
[PubMed]. HIV_01_2018.
4. Bioactive Triterpenoids from the Leaves and Twigs of Lithocarpus litseifolius and L. corneus. Cheng, Y.B., F.J. Liu, C.H. Wang, T.L. Hwang, Y.F. Tsai, C.H. Yen, H.C. Wang, Y.H. Tseng, C.T. Chien, Y.A. Chen, F.R. Chang, and Y.C. Wu. Planta Medica, 2018. 84(1): p. 49-58. PMID[28701018].
[PubMed]. HIV_01_2018.
5. Synthesis of Novel Heterocyclic Sulfonamides as Protease Inhibitors of HIV-1. Ding, Y.L., K.L. Smith, C. Prasad, and B.Y. Wang. Letters in Organic Chemistry, 2018. 15(2): p. 87-91. ISI[000419734300002].
[WOS]. HIV_01_2018.
6. The Traditional Use of Vachellia nilotica for Sexually Transmitted Diseases is Substantiated by the Antiviral Activity of its Bark Extract against Sexually Transmitted Viruses. Donalisio, M., V. Cagno, A. Civra, D. Gibellini, G. Musumeci, M. Ritta, M. Ghosh, and D. Lembo. Journal of Ethnopharmacology, 2018. 213: p. 403-408. PMID[29203273].
[PubMed]. HIV_01_2018.
7. O-GaINAcylation of RANTES Improves its Properties as a Human Immunodeficiency Virus Type 1 Entry Inhibitor. Guan, X.Y., P.K. Chaffey, H. Chen, W. Feng, X.L. Wei, L.M. Yang, Y. Ruan, X.F. Wang, Y.H. Li, K.B. Barosh, A.H. Tran, J.M. Zhu, W. Liang, Y.T. Zheng, X. Wang, and Z.P. Tan. Biochemistry, 2018. 57(1): p. 136-148. PMID[29202246].
[PubMed]. HIV_01_2018.
8. Identification of Novel Bifunctional HIV-1 Reverse Transcriptase Inhibitors. Lai, M.T., P. Tawa, A. Auger, D. Wang, H.P. Su, Y. Yan, D.J. Hazuda, M.D. Miller, E. Asante-Appiah, and R.A. Melnyk. The Journal of Antimicrobial Chemotherapy, 2018. 73(1): p. 109-117. PMID[29029095].
[PubMed]. HIV_01_2018.
9. Cycloartane Triterpenoid and its Glucoside Isolated from Cassia occidentalis. Li, S.F. and S.L. Li. Chinese Journal of Natural Medicines, 2017. 15(12): p. 950-954. PMID[29329653].
[PubMed]. HIV_01_2018.
10. Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding. Martini, R., F. Esposito, A. Corona, R. Ferrarese, E.R. Ceresola, L. Visconti, C. Tintori, A. Barbieri, A. Calcaterra, V. Iovine, F. Canducci, E. Tramontano, and M. Botta.ChemBioChem, 2017. 18(4): p. 374-377. PMID[27992102].
[PubMed]. HIV_01_2018.
11. Novel 4-Arylaminoquinoline-3-carbonitriles as Inhibitors of HIV-1 Reverse Transcriptase. Melo, B.C.L., A.M.R. Bernardino, G. Polillo, H.S. Pereira, I.C.P. Paixao, M.S. Ribeiro, and J.C. Borges. Journal of Heterocyclic Chemistry, 2017. 54(6): p. 3051-3055. ISI[000422654000009].
[WOS]. HIV_01_2018.
12. DNA Damage Induced by Topoisomerase Inhibitors Activates SAMHD1 and Blocks HIV-1 Infection of Macrophages. Mlcochova, P., S.J. Caswell, I.A. Taylor, G.J. Towers, and R.K. Gupta. The EMBO Journal, 2018. 37(1): p. 50-62. PMID[29084722]. PMCID[PMC5753034].
[PubMed]. HIV_01_2018.
13. Structure-based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-type and Drug-resistant HIV-1 Strains. Mori, M., L. Kovalenko, S. Malancona, F. Saladini, D. de Forni, M. Pires, N. Humbert, E. Real, T. Botzanowski, S. Cianferani, A. Giannini, M.C. Dasso Lang, G. Cugia, B. Poddesu, F. Lori, M. Zazzi, S. Harper, V. Summa, Y. Mely, and M. Botta. ACS Chemical Biology, 2018. 13(1): p. 253-266. PMID[29235845].
[PubMed]. HIV_01_2018.
14. Identification of Human anti-HIV gp160 Monoclonal Antibodies that Make Effective Immunotoxins. Pincus, S.H., K. Song, G.A. Maresh, D.H. Hamer, D.S. Dimitrov, W. Chen, M.Y. Zhang, V.F. Ghetie, P.Y. Chan-Hui, J.E. Robinson, and E.S. Vitetta. Journal of Virology, 2017. 91(3): p. e01955-01916. PMID[27852851]. PMCID[PMC5244328].
[PubMed]. HIV_01_2018.
15. Chloro-1,4-dimethyl-9H-carbazole Derivatives Displaying anti-HIV Activity.Saturnino, C., F. Grande, S. Aquaro, A. Caruso, D. Iacopetta, M.G. Bonomo, P. Longo, D. Schols, and M.S. Sinicropi. Molecules, 2018. 23(2): p. E286. PMID[29385738].
[PubMed]. HIV_01_2018.
16. Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 4-[4-Arylpyridin-1(4H)-yl] benzoic acid Derivatives as anti-HIV-1 Agents. Sepehri, S., S. Soleymani, R. Zabihollahi, M.R. Aghasadeghi, M. Sadat, L. Saghaie, and A. Fassihi. Chemistry & Biodiversity, 2017. 14(12): p. e1700295. PMID[28834275].
[PubMed]. HIV_01_2018.
17. The Croton megalobotrys Müll Arg. Traditional Medicine in HIV/AIDS Management: Documentation of Patient Use, in Vitro Activation of Latent HIV-1 Provirus, and Isolation of Active Phorbol Esters. Tietjen, I., B.N. Ngwenya, G. Fotso, D.E. Williams, S. Simonambango, B.T. Ngadjui, R.J. Andersen, M.A. Brockman, Z.L. Brumme, and K. Andrae-Marobela. Journal of Ethnopharmacology, 2018. 211: p. 267-277. PMID[28970153].
[PubMed]. HIV_01_2018.
18. Diterpenes from the Stem Bark of Euphorbia neriifolia and their in Vitro anti-HIV Activity. Yan, S.L., Y.H. Li, X.Q. Chen, D. Liu, C.H. Chen, and R.T. Li. Phytochemistry, 2018. 145: p. 40-47. PMID[29080411].
[PubMed]. HIV_01_2018.
19. Glycosylphosphatidylinositol-anchored anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice. Ye, C., W. Wang, L. Cheng, G. Li, M. Wen, Q. Wang, Q. Zhang, D. Li, P. Zhou, and L. Su. Journal of Virology, 2017. 91(3): p. e01389-01316. PMID[27881659]. PMCID[PMC5244347].
[PubMed]. HIV_01_2018.
20. Oxazole-containing Diterpenoids from Cell Cultures of Salvia miltiorrhiza and their anti-HIV-1 Activities. Zhang, D.W., J.M. Guo, M. Zhang, X. Liu, M.Y. Ba, X.Y. Tao, L.Y. Yu, Y. Guo, and J.G. Da. Journal of Natural Products, 2017. 80(12): p. 3242-3247. PMID[29185738].
[PubMed]. HIV_01_2018.
21. Twenty-nine New Limonoids with Skeletal Diversity from the Mangrove Plant, Xylocarpus moluccensis. Zhang, J., W. Li, Y. Dai, L. Shen, and J. Wu. Marine Drugs, 2018. 16(1): p. E38. PMID[29351263].PMCID[PMC5244347].
[PubMed]. HIV_01_2018.
22. Synthesis, Biological Evaluation and Molecular Docking Study of N-(2-Methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide Derivatives as Potent HIV-1 Vif Antagonists. Zhou, M., R.H. Luo, X.Y. Hou, R.R. Wang, G.Y. Yan, H. Chen, R.H. Zhang, J.Y. Shi, Y.T. Zheng, R. Li, and Y.Q. Wei. European Journal of Medicinal Chemistry, 2017. 129: p. 310-324. PMID[28235704].
[PubMed]. HIV_01_2018.
23. Creation of a Nanoformulated Cabotegravir Prodrug with Improved Antiretroviral Profiles. Zhou, T., H. Su, P. Dash, Z. Lin, B.L. Dyavar Shetty, T. Kocher, A. Szlachetka, B. Lamberty, H.S. Fox, L. Poluektova, S. Gorantla, J. McMillan, N. Gautam, R.L. Mosley, Y. Alnouti, B. Edagwa, and H.E. Gendelman. Biomaterials, 2018. 151: p. 53-65. PMID[29059541].
[PubMed]. HIV_01_2018.
Patent Citations
24. Preparation of Aza-substituted Triterpenoids as Inhibitors of Human Immunodeficiency Virus Replication. Chen, J., Y. Chen, A. Regueiro-Ren, S.-Y. Sit, and J. Swidorski. Patent. 2018. 2017-IB53878 2018002847: 199pp.
[Patent]. HIV_01_2018.
25. Preparation of Azadecalin Derivatives as Human Immunodeficiency Virus Replication Inhibitors for Treatment of AIDS and HIV Infection. Chen, J., N.A. Meanwell, A. Regueiro-Ren, S.-Y. Sit, and J. Swidorski. Patent. 2018. 2017-IB53879 2018002848: 267pp.
[Patent]. HIV_01_2018.
26. Preparation of Pyrimidine Derivatives for Treatment of AIDS. Liu, X., H. Zhang, P. Zhan, Z. Zhou, and D. Kang. Patent. 2018. 2016-CN89710
2018000450: 35pp; Chemical Indexing Equivalent to 166:28304 (CN).
[Patent]. HIV_01_2018.
27. Anti-HIV Compositions and Methods for Reactivating Latent Immunodeficiency Virus Using a Smyd2 Inhibitor. Ott, M. and D. Boehm. Patent. 2018. 2017-15488212 20180002699: 265pp, Cont -in-part of Appl No PCT/US2015/055377.
[Patent]. HIV_01_2018.
28. Synthesis of Triterpenoid Inhibitors of Human Immunodeficiency Virus Replication.Venables, B.L., J. Swidorski, N. Sin, and A. Regueiro-Ren. Patent. 2018. 2017-IB53880 2018002849: 85pp.
[Patent]. HIV_01_2018.